FBLG
FibroBiologics, Inc.
1.10$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 82.1% | 78.0% | 78.3% | 73.0% | 78.3% | 86.5% | 81.6% | 73.2% | 59.9% | 66.0% | 48.9% | 73.8% | |
| 81.0% | 77.5% | 71.6% | 67.0% | 74.8% | 85.0% | 75.9% | 63.6% | 55.7% | 50.9% | 25.0% | 44.3% | |
| 81.0% | 77.5% | 71.6% | 67.0% | 74.8% | 85.0% | 75.9% | 63.6% | 55.7% | 50.9% | 25.0% | 44.3% | |
| 20.8% | 89.4% | 133.9% | 126.8% | 73.9% | 83.4% | 79.4% | 93.8% | 98.6% | 36.0% | 56.2% | 41.5% | |
| 9.9% | 77.7% | 122.7% | 113.7% | 63.8% | 77.4% | 71.9% | 78.8% | 76.9% | 18.3% | 30.8% | 27.9% | |
| 2.7% | 3.1% | 7.3% | 7.5% | 4.8% | 58.2% | 54.7% | 62.5% | 59.7% | 7.3% | 16.3% | 4.8% | |
| 6.2% | 12.2% | 7.1% | 13.6% | 11.3% | 16.4% | 12.4% | 13.0% | 12.2% | 9.8% | 14.3% | 23.0% | |
| 79.2% | 10.6% | -33.9% | -26.8% | 26.1% | 16.6% | 20.6% | 6.2% | 1.4% | 64.0% | 43.8% | 58.5% | |
| -110.1% | -206.0% | -287.9% | -358.2% | -309.7% | -216.0% | -354.3% | -324.6% | -582.3% | -563.1% | -996.4% | -798.1% | |
| 12.2% | 13.5% | 13.7% | 18.4% | 16.0% | 10.6% | 16.0% | 13.9% | 24.6% | 34.6% | 63.5% | 47.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.